Skip to content


    Attention All WebMD Community Members:

    These message boards are closed to posting. Please head on over to our new WebMD Message Boards to check out and participate in the great conversations taking place:

    Your new WebMD Message Boards are now open!

    Making the move is as easy as 1-2-3.

    1. Head over to this page:

    2. Choose the tag from the drop-down menu that clicks most with you (and add it to any posts you create so others can easily find and sort through posts)

    3. Start posting

    Have questions? Email us anytime at [email protected]

    Breaking News: FDA Approves Zinbryta for RRMS
    Stephanie Butler, RN posted:
    The FDA approved Zinbryta for the treatment of RRMS. Zinbryta is a monoclonal antibody that is injected under the skin once a month. In clinical trials it was shown to be 45% more effective then Avonex (an interferon) in reducing relapse rates.
    Serious side effects including liver injury, skin reactions, and secondary immune conditions were seen in clinical trials, so Zinbryta should be reserved for people who have already tried at least two other DMTs.
    It is always helpful to expand the treatment options for RRMS, but hopefully we will hear news soon about Ocrelizumab, which is anticipated to be the first DMT approved for progressive MS.
    Was this Helpful?
    0 of 0 found this helpful

    Featuring Experts

    Stephanie knows multiple sclerosis as a patient and as a nurse. Stephanie was diagnosed with multiple sclerosis in 2013. Shortly after being diagnosed...More

    Helpful Tips

    Reliv does work
    I thought Reliv was a hoax too. But it's not. You need to take it regularly and consistently and it proves miracles. My mom was diagnosed ... More
    Was this Helpful?
    1 of 1 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.